UBS Group
PRAX icon

UBS Group’s Praxis Precision Medicines PRAX Stock Holding History

UBS Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.9M Buy
131,046
+22,600
+21% +$7.15M 0.01% 1876
2026
Q1 		$34.9M Buy
108,446
+19,246
+22% +$5.95M 0.01% 2002
2025
Q4 		$26.3M Sell
89,200
-7,612
-8% -$1.42M ﹤0.01% 2318
2025
Q3 		$5.13M Buy
96,812
+10,278
+12% +$498K ﹤0.01% 4006
2025
Q2 		$3.64M Sell
86,534
-106,375
-55% -$4.05M ﹤0.01% 4202
2025
Q1 		$7.31M Buy
192,909
+72,642
+60% +$4.54M ﹤0.01% 3387
2024
Q4 		$9.26M Buy
120,267
+90,717
+307% +$6.56M ﹤0.01% 3143
2024
Q3 		$1.7M Buy
29,550
+2,773
+10% +$150K ﹤0.01% 4158
2024
Q2 		$1.11M Buy
26,777
+26,769
+334,613% +$1.27M ﹤0.01% 4329
2024
Q1 		$488 Sell
8
-2,691
-100% -$121K ﹤0.01% 8523
2023
Q4 		$60.1K Buy
+2,699
New +$48.6K ﹤0.01% 6446
2023
Q3 		– Sell
-508
Closed -$8.76K – 9852
2023
Q2 		$8.76K Sell
508
-808
-61% -$12.4K ﹤0.01% 7213
2023
Q1 		$16K Buy
1,316
+632
+92% +$26.7K ﹤0.01% 7258
2022
Q4 		$24.4K Buy
+684
New +$21.3K ﹤0.01% 7443
2022
Q3 		– Sell
-10,447
Closed -$384K – 10791
2022
Q2 		$384K Buy
10,447
+5,652
+118% +$603K ﹤0.01% 4457
2022
Q1 		$734K Sell
4,795
-945
-16% -$194K ﹤0.01% 4396
2021
Q4 		$1.7M Buy
5,740
+5,736
+143,400% +$1.68M ﹤0.01% 3887
2021
Q3 		$1K Buy
+4
New +$1.08K ﹤0.01% 9224
2021
Q1 		– Sell
-7,759
Closed -$6.4M – 9361
2020
Q4 		$6.4M Buy
+7,759
New +$4.53M ﹤0.01% 2214

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

UBS Group's PRAX Position: Q2 2026 in Review

UBS Group increased its Praxis Precision Medicines (PRAX) stake by 21% in Q2 2026, buying an estimated $7.15M and bringing the position to 131,046 shares worth $43.9M. The position accounts for 0.01% of the portfolio, ranked #1876.

UBS Group first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • UBS Group held 131,046 shares of Praxis Precision Medicines worth $43.9M as of Q2 2026.
  • UBS Group bought 22,600 Praxis Precision Medicines shares in Q2 2026, an estimated $7.15M.
  • Praxis Precision Medicines made up 0.01% of UBS Group's portfolio in Q2 2026, its #1876 holding.
  • UBS Group first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.